Novel 1,5-benzothiazepin-4-(5H)-one derivatives (8a-8g) have been synthesized by intramolecular cyclization of 6 using propyl phosphonic anhydride (T3P) as a cyclodehydrating agent. The anti-angiogenic and anti-oxidant properties of the new derivatives were then evaluated. Compounds 8b, 8d, 8e, 8f and 8g exhibited very good inhibition of capillary proliferation, thus proving their anti-angiogenic properties. In addition, the in vitro antioxidant activities of these compounds were evaluated using diphenyl picryl hydrazine (DPPH), OH -, metal ion-chelating and NO (nitric oxide) assays, and the results compared with butylated hydroxytoluene (BHT), a well known anti-oxidant. Compounds 8a-8g showed excellent free-radical scavenging activities in the metal ion-chelating assay, and compounds 8f and 8g showed nitric oxide radical scavenging properties at a concentration of 20-100 µg/mL, and are thus more potent than BHT.
Introduction
Angiogenesis is the development of new blood vessels from pre-existing vasculatures and this has been well recognized as an essential hallmark for the growth, invasion and metastasis of tumors. 1 Deregulation of angiogenesis under pathological conditions causes several diseases like diabetic retinopathy, rheumatoid arthritis, and cancer. 2 Thus, the inhibition of tumor angiogenesis provides a therapeutic strategy for treating different types of cancers. In many cases anti-angiogenic agents act as cytostatics and prevent the growth of tumors, though it is thought that they can be made more successful in cancer chemotherapy by combining with cytotoxic agents. 3 Antioxidants are molecules inhibiting the oxidation of other molecules thereby preventing the cell death that occurs due to the release of free radicals. 4 Reactive oxygen species generated in the cell during anti-oxidation initiate and promote tumor growth as well as other degenerative diseases such as heart attacks, strokes, arthritis and cataracts. 5 Minimizing oxidative damage may be an important approach to the primary treatment of these diseases, since antioxidants prevents the free radical formation, or interrupt an oxidizing chain reaction. Thus, antioxidants can be regarded as important factors for the treatment of cancer. Compounds functioning with groups endowed with potential antioxidant properties are considered as new drugs for chemoprevention and chemotherapy. 6 Therefore, the development of synthetic compounds, capable of scavenging free radicals, has been a great interest. 1,5-Benzothiazepines constitute an important class of privileged scaffolds as a result of their immense chemotherapeutic applications, such as calcium channel blockers, 7 angiotensin converting enzyme inhibitors, 8 anticonvulsant, 9 anti-HIV, 10 anti-hypertensive, 11 platelet aggregation inhibitors 12 and cytotoxic 13 agents. They have also been reported as potent antibacterial, 14 antimicrobial, 15 and Bradykinin agonists.
16 Diltiazem [ Fig. 1 ], 17 a well-known angina-relieving calcium channel blocker and coronary vasodilator, and Thiazesim, 18 used as an antidepressant, and the antipsychotic Quetiapine, 19 possess 1,5-benzothiazepine skeletons.
Because of their interesting biological properties, functionalized 1,5-benzothiazepin-4(5H)ones represent an important class of heterocyclic compounds. The major approaches, for synthesis of 1,5-benzothiazepinones are cyclization and ring expansion. The most widely employed methods involves, nucleophilic attack of substituted 2-aminothiophenols or 2-nitrothiophenols on aliphatic electrophiles 20 and the reaction of 2-fluoronitroarenes with β-mercapto acid, followed by nitro group reduction and cyclisation. 21 (Scheme 1).
Scheme 1. Synthetic methods for preparation of 1,5-benzothiazepin-4(5H)-ones
In continuation of our work on development of synthetic methodologies for bioactive molecules, 22, 23 we report herein an efficient, versatile and convenient synthetic route which provides rapid access to 1,5-benzothiazepin-4(5H)-ones using a multistep strategy from readily available diethyl di-n-butyl malonate 1 and a new coupling agent T3P ( Figure 2 ) and their anti-angiogenic and anti-oxidant properties. 
Chemistry
The synthesis of 1,5-benzothiazepin-4(5H)-one derivatives was accomplished in seven steps as outlined in Scheme 2.
(a) DIBAL-H, NaBH4; (b) NaOH, MeOH; (c) HBr, conc. H2SO4; (d) aq. KOH, 4, THF; (e) T3P, Et3N; (f) DMF, NaH, RX. Scheme 2. Synthetic route of 1,5-benzothiazepin-4(5H)-one derivatives First, ethyl-[2-n-butyl-2-hydroxymethyl]hexanoate 2 was obtained by selective reduction of diethyl di-n-butyl malonate 1 in toluene using DIBAL−H and NaBH4 under N2 atmosphere. Compound ethyl-(2-n-butyl-2-hydroxymethyl)hexanoic acid 3 was then synthesized in good yield by hydrolysis of ethyl-(2-n-butyl-2-hydroxymethyl)hexanoate 2 in methanol and NaOH. 2-Bromomethyl-2-n-butylhexanoic acid 4 was then obtained by treating ethyl-(2-n-butyl-2-hydroxymethyl)hexanoic acid 3 with 48% (aq.) HBr and conc. H2SO4. Amino-6-methoxy benzothiazole 5 in KOH solution was condensed with 2-bromomethyl-2-n-butylhexanoic acid 4 in THF under N2 atmosphere to yield the desired product, 2-{[(2-amino-5-methoxyphenyl)thio]methyl}-2-n-butylhexanoic acid 6. Finally, the intramolecular cyclization of 6 using T3P as cyclodehydrating agent afforded the compound 3,3-di-n-butyl-8-methoxy-2,3-dihydro-1,5-benzothiazepin-4(5H)-one 7. Compounds 8a-8g were obtained in good yields (85-92%) by alkylation of 7 with different alkyl halides in DMF using NaH as a base under N2 atmosphere. We concluded, based on previously published work, that this is the first report in which T3P is used as a cyclodehydrating agent in the synthesis of the 1,5-benzothiazepin-4(5H)-one core structure 7. The structures of all the synthesized compounds were confirmed by IR, 1 H NMR and mass spectra.
2.2.Antioxidant activities

DPPH radical scavenging activity
Antioxidants are characterized by their ability to scavenge free radicals. Proton-radical scavenging action is an important attribute of antioxidants, which is measured by DPPH scavenging assay. DPPH, a protonated radical has significant absorbance maxima at 517 nm which decreases in the presence of antioxidant due to the scavenging of the proton radical 24 . The hydrogen donating ability of the antioxidant molecule contributes to its free radical scavenging potential. The DPPH radical scavenging activity shown by compounds 8a-8g is due to their H-donating capacity. In the present investigation, compounds 8a-8g showed low DPPH radical-scavenging activities when compared to BHT (IC50 values from 136.36 µg/mL to 661.03 µg/mL, BHT has an IC50 value of 10.87 µg/mL).
Hydroxyl radical scavenging activity
The hydroxyl radical is an extremely reactive free radical formed in biological systems and has been implicated as a highly damaging species in free radical pathology as it is capable of damaging biomolecules found in living cells. 25 Hydroxyl radical has the capacity to cause breakage of DNA, which results in cytotoxicity, carcinogenesis and mutagenesis. In addition, this radical species is rapidly initiates lipid peroxidation, removing hydrogen atoms from unsaturated fatty-acids. 25 In the present study, 8a-8g showed moderate hydroxyl radical scavenging activity (8f with IC50 value of 13.64 µg and 8b showing 82.94 µg/mL) when compared to standard BHT (IC50 value 10.83 µg/mL). The hydrogen-donating capacity of compounds 8a-8g was observed to be moderate compared to BHT as shown in Table 1 . 
Nitric oxide radical scavenging activity
Under physiological conditions, nitric oxide (NO) plays important roles as a neurotransmitter, vasodilator and in the immunological system it fights against tumor cells and infectious agents. During inflammatory reactions, NO is produced by the inducible enzyme NO synthase (iNOS) in cells like macrophages, hepatocytes, and renal cells after stimulation by lipopolysaccharide (LPS), tumor necrosis factor (TNF-α), interleukin (IL-1) or interferon (INF-γ), and acts as a defense and regulatory signal molecule. However, NO is pathogenic when present in excess, as it is a reactive radical itself, and directly damages normal tissues. 26 Further, NO can also react with superoxide anion radical to form the even stronger oxidant, peroxynitrite. 27 Among the samples studied, 8g and 8f showed highly significant (P < 0.01) activity in scavenging NO radical with IC50 values of 16.55 and 35.01 µg/mL, respectively, when compared to 51.79 µg/mL recorded for BHT (Table 1) 
Ferrous ion chelating ability
Iron is known to generate free radicals through the Fenton and Haber-Weiss reactions. 28 Metal ion chelating activity of an antioxidant molecule prevents oxy-radical generation and consequent oxidative damage. Metal ion-chelating capacity plays a significant role in anti-oxidant mechanism since it reduces the concentration of the catalyzing transition metal in lipid peroxidation. It is reported that chelating agents, which form sigma-bonds with a metal, are effective as secondary antioxidants because they decrease the redox potential of the metal centre, thereby stabilizing the oxidized form of the metal ion. 29 By virtue of both metal chelating properties and radical scavenging ability, compounds 8a-8g may have a role in the prevention of free radicals with IC50 values ranging from 39.59 µg/mL for 8d to 105.60 µg/mL for 8c (BHT IC50 value = 213.45 µg/mL).
Antiangiogenic activity
Anti-angiogenic treatment is one of the main methods of tumor treatment and control of pathological angiogenesis. 30 Pathological angiogenesis is regulated by targeting integrins, which are predominantly expressed in most of the tumor cells and endothelial cells of blood vessels. The interaction of vascular endothelial growth factor (VEGF) and its receptors in a signal transduction pathway also regulates angiogenesis. 31 In the present investigation, some of the compounds among 8a-8g reduced the proliferation of blood vessels in the shell-less CAM assay model with developing embryos. The proliferation of microvessels was repressed only in group treated with compounds 8b, 8d, 8e, 8f and 8g (Fig. 5) 
Conclusion
In the present study, novel 1,5-benzothiazepin-4(5H)-one derivatives have been synthesized and their antioxidant and antiangiogenic activities have been assessed. Oxidative stress and angiogenesis are important biological mechanisms by which tumorgenesis and tumor progression occur. Antiangiogenic determined in the shell-less CAM model revealed that 8b, 8d, 8e, 8f and 8g compounds are endowed with interesting anti-tumor activities. Further, antioxidants have proved to protect against oncogenic transformations resulting from radiation and free-radicals in experimental systems. 31 The significant multiple antioxidant activities of 1,5-benzothiazepin-4(5H)-one derivatives, especially the high ferrous ion chelating ability of 8a-8g and nitric oxide radical scavenging activity of 8f and 8g, appear to protect the cells by neutralizing or trapping reactive oxygen species and other free radicals. These results conclusively prove that rational design of 1,5-benzothiazepin-4(5H)-one derivatives can be used to create anti-angiogenic and antioxidant agents. 
Experimental
General
All reagents were purchased from Sigma Aldrich Chemicals. Infrared (IR) spectra were recorded on a JASCO FT/IR-4100 spectrophotometer in KBr disc for solid compounds and nujol for liquids and are reported in reciprocal wave number (cm -1 ).
1 H NMR spectra were recorded in DMSO-d6 at 300 and 400 MHz. The following abbreviations are used for structural assignments of 1 H NMR: s, singlet; d, doublet; t, triplet; dd, doublet of doublets; m, multiplet and br, broad. Mass and purity were recorded on a LC-MSD-Trap-XCT. Thin layer chromatography was performed using 600 mesh silica gel plates, and visualization was effected with short wavelength UV light (254 nm). All other commercial reagents were used as received.
General procedure for the synthesis of Ethyl-[2-n-butyl-2-hydroxy methyl]hexanoate (2)
Diethyl di-n-butyl malonate ( 
General procedure for the synthesis of Ethyl-[2-n-butyl-2-hydroxy methyl]hexanoic acid (3)
To a stirred solution of ethyl- [2- 
General procedure for the synthesis of 2-Bromomethyl-2-n-butylhexanoic acid (4)
To a solution of 48% (aq.) hydrobromic acid was added slowly concentrated H2SO4 below 
General procedure for the synthesis of 2-{[(2-Amino-5-methoxyphenyl)thio]methyl}-2-nbutylhexanoic acid (6)
To a stirred solution of amino-6-methoxy benzothiazole (4.00 g, 0.022 mol) in water (44 mL) was added KOH (12. General procedure for the synthesis of 3,3-di-n-butyl-8-methoxy-2,3-dihydro-1,5- 
benzothiazepin-4-(5H)-one (7):
To a stirred solution of 4 (3.00 g, 0.0088 mol) in ethyl acetate (27 mL), was added triethylamine (1.95 g, 0.0193 mol). The reaction mixture was cooled to 0 o C and T3P (2.81 g, 0.0088 mol) added at 0 o C, then stirred at 25 o C for 3 h and diluted with ethyl acetate. The above organic layer was washed with 10% NaHCO3 solution, then water, brine, dried over sodium sulfate and concentrated under vacuum at 50 o C to obtain a crude product which was purified by chromatography on silica gel using ethyl acetate and hexane. Brown solid, yield 3.6 g, 90%; FT-IR (KBr) υ/cm -1 : 3092, 2867, 1213, 1644; 1 H NMR (400 MHz, DMSO-d6): δ = 9. 48 (s, 1 H), 7.00 (d, 1 H, J = 8.4), 6.93 (d, 1 H, J = 2.8), 6.82 (q, 1 H, J = 2.8), 3.69  (s, 3 H), 2.94 (s, 2 H), 1.39-1.46 (m, 4 H), 1.14-1.39 (m, 8 H) , 0.80 (t, 6 H, J = 8.6); MS (ES) m/z (m+1): 322.0.
General procedure for the synthesis of 3,3-Dibutyl-8-methoxy-5-alkyl-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one (8)
A solution of 5 (0.20 g, 0.62 mmol) in DMF (3 mL) was cooled to 0 o C under N2 atmosphere and NaH (0.0223g, 0.933 mmol) added and stirred for 15 min. To this reaction mixture, methyl iodide (0.0425 mL) was added and the reaction mixture allowed to stir for one hour at room temperature. Progress of the reaction was monitored by TLC. When the reaction was complete, the reaction mixture was diluted with water (30 mL) and extracted with ethyl acetate (25 mL × 2). The organic layer was dried over anhydrous sodium sulfate, and concentrated under vacuum to afford a crude product, which was purified by chromatography on silica gel using ethyl acetate and hexane.
3,3-Dibutyl-8-methoxy-5-methyl-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one (8a)
Colorless semi-solid, 1 
5-Allyl-3,3-dibutyl-8-methoxy-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one (8c)
Colorless semi-solid; 1 7. 3,3-Dibutyl-8-methoxy-5(2-piperidin-1-yl-ethyl)2,3-dihydro-5H-benzo[b] [1, 4] 32 Briefly, DPPH solution (1 mL, 0.1 mM in 95% ethanol) was mixed with different aliquots of 8a-8g. After vigorous shaking, the mixture was allowed to stand for 20 min at room temperature. Absorbance of the resulting solution was measured at 517 nm with a UV-VIS spectrophotometer (HITACHI, U-2900). Butylated hydroxyl toluene (BHT) was used as positive control. Radical scavenging potential is expressed as IC50 value, which represents the sample concentration at which 50 % of DPPH radicals are scavenged.
2-(3,3-Dibutyl-8-methoxy-4-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazepin-5-yl)-N-isopropylacetamide (8f)
Off
4.7.
Hydroxyl radical scavenging assay
The reaction mixture containing different aliquots of 8a-8g, deoxyribose (10 mM), H2O2 (10 mM), FeCl3 (5 mM), EDTA (1 mM) and ascorbic acid (5 mM) in potassium phosphate buffer (50 mM, pH 7.4) was allowed to stand for 60 min at 37 o C. 33 The reaction was terminated by adding TCA (5% W/V) and the reaction product was measured by reaction with TBA (0.2% W/V) in boiling water bath for 15 min. The absorbance was measured at 535 nm against the reagent blank and inhibition of the oxidation of deoxyribose was calculated against the control using UV-VIS spectrophotometer (HITACHI, U-2900). BHT was used as positive control and radical scavenging potential was expressed as IC50 value.
Nitric oxide radical scavenging activity
Nitric oxide was generated from sodium nitroprusside and measured by Griess reaction. Sodium nitroprusside in phosphate buffer at physiological pH spontaneously generates nitric oxide, which in turn reacts with oxygen to produce nitrite ions that can be estimated by the Griess reagent. 34 Nitric oxide scavengers compete with oxygen, leading to reduced production of nitric oxide. Sodium nitroprusside (5 mM) in phosphate buffered saline was mixed with different aliquots of 8a-8g and incubated at 25 ºC for 3 h. The absorbance of the color formed during the diazotization of nitrite with sulphanilamide and subsequent coupling with napthylethylenediamine was read at 546 nm and referred with the absorbance of BHT treated in the same way with the Griess reagent. The radical scavenging potential was calculated and expressed as IC50 value.
Ferrous ion chelating ability
Ferrous ion chelating ability was measured according to the method of Suter and Richter. 35 Three sets of test tubes were taken; the first tube as control: To this 40 µL of FeCl3 (200 µM) and 80 µL of K3Fe(CN)6 (400 mM ) were added and the volume was made up to 1 mL by adding distilled water. For the second tube 20 µL of EDTA (400 mM), 40 mL of FeCl3 and 80 µL K3Fe(CN)6 were added and the volume was made up to 1 mL by adding distilled water. For the third sample (10 µg-100 µg), 40 µL of FeCl3 and 80 µL of K3Fe(CN)6 were added and the volume was made up to 1 mL by adding distilled water. The tubes were incubated for 10 min at 20 o C and the OD read at 700 nm. The assay was carried out at 20 o C to prevent Fe 2+ oxidation.
Antiangiogenic activity
Fertilized eggs were obtained from IVRI, Bangalore, India. All chemicals were purchased from Sisco Research Laboratories, Mumbai, India and they were of analytical grade. Antiangiogenic effects of 8a-8g compounds was studied according to the method of Auerbach et al. 36 . Briefly, fertilized hens eggs were surface sterilized using 70% alcohol. The eggs were incubated in fan assisted humidified incubator at 37 ºC. On the 4 th day, the eggs were cracked out into thin films of the hammock within a laminar flow cabinet and were further incubated. On day 5 th when blood vessels were seen proliferating from the center of the eggs within the hammock, filter paper discs loaded with 100 µg of the compounds 8a-8g were placed over the proliferating blood vessels and the eggs were returned to the incubator. Results of antiangiogenic effects of the compounds were noted after 24 h.
